GCP
IGMS

GSA Capital Partners’s IGM Biosciences IGMS Stock Holding History

GSA Capital Partners’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-425,303
Closed -$489K – 1928
2025
Q1 		$489K Buy
425,303
+331,821
+355% +$617K 0.04% 817
2024
Q4 		$571K Buy
93,482
+36,728
+65% +$436K 0.04% 785
2024
Q3 		$939K Sell
56,754
-5,227
-8% -$57.3K 0.07% 509
2024
Q2 		$426K Buy
61,981
+43,583
+237% +$373K 0.03% 1068
2024
Q1 		$178K Buy
+18,398
New +$213K 0.01% 1427
2023
Q4 		– Sell
-133,276
Closed -$1.11M – 1692
2023
Q3 		$1.11M Buy
133,276
+26,358
+25% +$224K 0.1% 339
2023
Q2 		$987K Buy
106,918
+59,733
+127% +$669K 0.1% 315
2023
Q1 		$648K Buy
47,185
+17,324
+58% +$358K 0.06% 551
2022
Q4 		$508K Buy
29,861
+11,682
+64% +$234K 0.06% 592
2022
Q3 		$413K Sell
18,179
-3,738
-17% -$75.5K 0.05% 720
2022
Q2 		$395K Sell
21,917
-14,600
-40% -$260K 0.06% 649
2022
Q1 		$976K Buy
36,517
+28,847
+376% +$537K 0.13% 189
2021
Q4 		$225K Buy
7,670
+2,265
+42% +$113K 0.03% 1135
2021
Q3 		$355K Buy
5,405
+509
+10% +$38.9K 0.04% 905
2021
Q2 		$407K Buy
4,896
+1,064
+28% +$78.8K 0.05% 769
2021
Q1 		$294K Sell
3,832
-2,719
-42% -$247K 0.05% 658
2020
Q4 		$578K Buy
+6,551
New +$460K 0.09% 342

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

GSA Capital Partners's IGMS Position: Q2 2025 in Review

GSA Capital Partners sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 425,303 shares — an estimated $489K sold.

GSA Capital Partners first reported a position in IGMS in Q4 2020 and held it in 17 quarters. The position peaked at $1.11M in Q3 2023. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • GSA Capital Partners reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 425,303 IGM Biosciences shares in Q2 2025, an estimated $489K.
  • GSA Capital Partners first reported a position in IGM Biosciences in Q4 2020 and held it in 17 quarters.
  • GSA Capital Partners's IGM Biosciences position peaked at $1.11M in Q3 2023.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.